{"id":2003,"date":"2016-07-28T09:31:10","date_gmt":"2016-07-28T09:31:10","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/?p=2003"},"modified":"2016-07-28T09:31:10","modified_gmt":"2016-07-28T09:31:10","slug":"major-funding-received-to-reduce-infections-in-patients-with-liver-failure","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/07\/28\/major-funding-received-to-reduce-infections-in-patients-with-liver-failure\/","title":{"rendered":"Major Funding Received to Reduce Infections in Patients with Liver Failure"},"content":{"rendered":"<div class=\"fcbkbttn_buttons_block\" id=\"fcbkbttn_left\"><div class=\"fcbkbttn_button\">\n\t\t\t\t\t<a href=\"https:\/\/www.facebook.com\/\" target=\"_blank\">\n\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-content\/plugins\/facebook-button-plugin\/images\/standard-facebook-ico.png\" alt=\"Fb-Button\" \/>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div><div class=\"fcbkbttn_like \"><fb:like href=\"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/2016\/07\/28\/major-funding-received-to-reduce-infections-in-patients-with-liver-failure\/\" action=\"like\" colorscheme=\"light\" layout=\"standard\"  width=\"225px\" size=\"small\"><\/fb:like><\/div><\/div><p>Dr Harry Antoniades &#8211; Reader and Consultant Hepatologist working in Digestive Diseases,\u00a0has received substantial funding with Imperial College sponsoring the study to run a 3-year multi centre clinical trial called R-RID. The trial will be looking at the use of selective intestinal decontamination to reduce infections in patients with liver failure.<\/p>\n<p>Due to start on October the trial will be run in conjunction with The Royal Liverpool University Hospitals, University Hospitals Birmingham, Chelsea &amp; Westminster Hospital and Firmly Health NHS Trusts. The two big collaborating liver centres are Birmingham Liver Unit and Liverpool.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr Harry Antoniades &#8211; Reader and Consultant Hepatologist working in Digestive Diseases,\u00a0has received substantial funding with Imperial College sponsoring the study to run a 3-year multi centre clinical trial called R-RID. The trial will be looking at the use of selective intestinal decontamination to reduce infections in patients with liver failure. Due to start on [&hellip;]<\/p>\n","protected":false},"author":710,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2003","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/users\/710"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/comments?post=2003"}],"version-history":[{"count":1,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2003\/revisions"}],"predecessor-version":[{"id":2004,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/posts\/2003\/revisions\/2004"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/media?parent=2003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/categories?post=2003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/surgeryandcancer\/wp-json\/wp\/v2\/tags?post=2003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}